These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Our experience on the association of a new physical and medical therapy in patients suffering from induratio penis plastica. Mirone V; Imbimbo C; Palmieri A; Fusco F Eur Urol; 1999 Oct; 36(4):327-30. PubMed ID: 10473993 [TBL] [Abstract][Full Text] [Related]
9. Long-term experiences with high-energy shock wave therapy in the management chronic phase Peyronie's disease using two different electromagnetic lithotripters. Rassweiler JJ; Scheitlin W; Goezen AS; Radecke F World J Urol; 2024 Mar; 42(1):124. PubMed ID: 38453751 [TBL] [Abstract][Full Text] [Related]
10. Extracorporeal shock wave therapy in the treatment of Peyronie's disease: long-term results. De Berardinis E; Busetto GM; Antonini G; Giovannone R; Gentile V Arch Ital Urol Androl; 2010 Jun; 82(2):128-33. PubMed ID: 20812541 [TBL] [Abstract][Full Text] [Related]
11. Preliminary findings from a new animal model for Peyronie's disease involving extracorporeal shock waves. Andrade E; Cortez I; Claro J; Pompeu E; Leite K; Paranhos M; Borra P; Lucon AM; Srougi M BJU Int; 2009 Apr; 103(8):1104-6. PubMed ID: 19021616 [TBL] [Abstract][Full Text] [Related]
12. Extracorporeal shockwave therapy for Peyronie's disease: an alternative treatment? Poulakis V; Skriapas K; de Vries R; Dillenburg W; Ferakis N; Witzsch U; Melekos M; Becht E Asian J Androl; 2006 May; 8(3):361-6. PubMed ID: 16625288 [TBL] [Abstract][Full Text] [Related]
13. Shockwave therapy as first-line treatment for Peyronie's disease: a prospective study. Skolarikos A; Alargof E; Rigas A; Deliveliotis Ch; Konstantinidis E J Endourol; 2005; 19(1):11-4. PubMed ID: 15735375 [TBL] [Abstract][Full Text] [Related]
14. Ultrasound in patients affected with Peyronie's disease. Fornara P; Gerbershagen HP World J Urol; 2004 Nov; 22(5):365-7. PubMed ID: 15672280 [TBL] [Abstract][Full Text] [Related]
15. Extracorporal shock wave therapy in the treatment of Peyronie's disease. First results of a case-controlled approach. Hauck EW; Altinkilic BM; Ludwig M; Lüdecke G; Schroeder-Printzen I; Arens C; Weidner W Eur Urol; 2000 Dec; 38(6):663-9;discussion 670. PubMed ID: 11111181 [TBL] [Abstract][Full Text] [Related]
16. Low-intensity laser diode plus extracorporeal shock wave therapy: a new treatment strategy in the management of Peyronie's disease. Dell'Atti L; Ronchi P World J Urol; 2023 Sep; 41(9):2563-2568. PubMed ID: 37490060 [TBL] [Abstract][Full Text] [Related]
17. [Extracorporeal shock-wave therapy in the treatment of Peyronie's disease]. Neĭmark AI; Astakhov IuI; Sidor MV Urologiia; 2004; (2):33-5. PubMed ID: 15114750 [TBL] [Abstract][Full Text] [Related]
18. Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study. Pavone C; Napoli G; Caruana G; Alonge V; Usala M; Abbadessa D BJU Int; 2012 Jul; 110(1):117-21. PubMed ID: 22176734 [TBL] [Abstract][Full Text] [Related]
19. An alternative non-invasive treatment for Peyronie's disease. Claro JA; Passerotti CC; Figueiredo Neto AC; Nardozza A; Ortiz V; Srougi M Int Braz J Urol; 2004; 30(3):199-204; discussion 204. PubMed ID: 15689246 [TBL] [Abstract][Full Text] [Related]
20. Extracorporeal shock wave therapy in the treatment of Peyronie's disease: experience with standard lithotriptor (siemens-multiline). Lebret T; Loison G; Hervé JM; Mc Eleny KR; Lugagne PM; Yonneau L; Orsoni JL; Saporta F; Butreau M; Botto H Urology; 2002 May; 59(5):657-61. PubMed ID: 11992835 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]